Fetal Alloimmune Thrombocytopenia
- 3 July 1997
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (1) , 22-26
- https://doi.org/10.1056/nejm199707033370104
Abstract
Alloimmune thrombocytopenia is a serious fetal disorder resulting from platelet-antigen incompatibility between the mother and fetus. The diagnosis is usually made after the discovery of unexpected neonatal thrombocytopenia. Approximately 10 to 20 percent of affected fetuses have intracranial hemorrhages, one quarter to one half of which occur in utero. We studied the correlates of thrombocytopenia in affected fetuses.Keywords
This publication has 25 references indexed in Scilit:
- Alloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesisAmerican Journal of Obstetrics and Gynecology, 1995
- Antenatal management of fetomaternal alloimmune thrombocytopenia—report of 15 affected pregnanciesTransfusion Medicine, 1994
- Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopeniaThe Lancet, 1992
- In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopeniaThe Lancet, 1992
- HPA‐5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 casesBritish Journal of Haematology, 1991
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988
- PRENATAL TREATMENT OF FETAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1988
- IN-UTERO PLATELET TRANSFUSION FOR ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1988
- In Utero Cerebral Hemorrhage in Alloimmune ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1986
- PRENATAL TREATMENT OF ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1984